Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) – Stock analysts at Zacks Research lowered their Q3 2025 earnings per share (EPS) estimates for Acadia Healthcare in a research note issued to investors on Wednesday, December 18th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings of $0.97 per share for the quarter, down from their prior estimate of $0.98. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period in the prior year, the company earned $0.91 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year.
Read Our Latest Report on ACHC
Acadia Healthcare Price Performance
ACHC stock opened at $37.90 on Friday. The company has a fifty day simple moving average of $44.14 and a two-hundred day simple moving average of $61.09. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $3.52 billion, a P/E ratio of 12.43, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Blue Trust Inc. raised its position in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the period. GAMMA Investing LLC increased its stake in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Acadia Healthcare in the second quarter valued at approximately $59,000. Covestor Ltd boosted its stake in shares of Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after acquiring an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare during the third quarter worth approximately $86,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- What is the S&P 500 and How It is Distinct from Other Indexes
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Stock Market Upgrades: What Are They?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.